REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,544,183 | +2.5% | 1,211,856 | -1.0% | 0.01% | +10.0% |
| Q2 2023 | $32,734,649 | +34.5% | 1,223,725 | +8.9% | 0.01% | +25.0% |
| Q1 2023 | $24,344,929 | +45.8% | 1,123,958 | +60.4% | 0.01% | +33.3% |
| Q4 2022 | $16,694,000 | -14.7% | 700,923 | -29.4% | 0.01% | -14.3% |
| Q3 2022 | $19,566,000 | +0.3% | 993,063 | -0.8% | 0.01% | 0.0% |
| Q2 2022 | $19,500,000 | -21.2% | 1,001,308 | +3.2% | 0.01% | 0.0% |
| Q1 2022 | $24,754,000 | +2.3% | 970,514 | +1.0% | 0.01% | 0.0% |
| Q4 2021 | $24,196,000 | -8.3% | 961,296 | +0.2% | 0.01% | -12.5% |
| Q3 2021 | $26,393,000 | -11.3% | 959,227 | +2.3% | 0.01% | -11.1% |
| Q2 2021 | $29,740,000 | +54.3% | 937,485 | +123.2% | 0.01% | +50.0% |
| Q1 2021 | $19,269,000 | +79.3% | 420,007 | +54.8% | 0.01% | +50.0% |
| Q4 2020 | $10,744,000 | +513.9% | 271,325 | +440.1% | 0.00% | +300.0% |
| Q3 2020 | $1,750,000 | +24.6% | 50,239 | +13.0% | 0.00% | 0.0% |
| Q2 2020 | $1,404,000 | +0.9% | 44,444 | -30.0% | 0.00% | 0.0% |
| Q1 2020 | $1,392,000 | – | 63,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |